Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARPAC2: ATRA + Gemcitabine + nab-Paclitaxel in Pancreatic Cancer
NCT04241276Phase 2Active, not recruiting
- Sponsor
- Queen Mary University of London
- Start
- Apr 2020
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin in pancreatic cancer (PC), sponsored by Queen Mary University of London. Started Apr 2020; status: active, not recruiting.
02
Drugs
tretinoin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04241276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04241276.